tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market
Advertisement

Concord Biotech Ltd. (CONCORDBIO) Income Statement

Compare
2 Followers

Concord Biotech Ltd. Income Statement

Last quarter (Q1 2026), Concord Biotech Ltd.'s total revenue was ₹2.04B, a decrease of -5.47% from the same quarter last year. In Q1, Concord Biotech Ltd.'s net income was ₹440.58M. See Concord Biotech Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 12.00B₹ 10.17B₹ 8.53B₹ 7.13B₹ 6.17B
Gross Profit
₹ 7.68B₹ 6.67B₹ 6.61B₹ 5.41B₹ 5.00B
Operating Expenses
₹ 1.66B₹ 1.46B₹ 1.43B₹ 1.25B₹ 699.61M
Depreciation and Amortization
₹ 526.08M₹ 518.51M₹ 527.85M₹ 487.98M₹ 263.27M
EBITDA
₹ 5.13B₹ 4.39B₹ 3.53B₹ 2.78B₹ 3.29B
Operating Income
₹ 6.02B₹ 5.21B₹ 5.18B₹ 4.16B₹ 4.30B
Other Income/Expenses
₹ -1.07B₹ -1.09B₹ -1.96B₹ -1.79B₹ -1.17B
Pretax Income
₹ 4.95B₹ 4.13B₹ 3.22B₹ 2.38B₹ 3.13B
Net Income
₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B
Per Share Metrics
Basic EPS
₹ 35.52₹ 29.45₹ 22.95₹ 16.72₹ 22.45
Diluted EPS
₹ 35.52₹ 29.45₹ 22.95₹ 16.72₹ 22.45
Weighted Average Shares Outstanding
104.62M 104.62M 104.62M 104.62M 104.63M
Weighted Average Shares Outstanding (Diluted)
104.62M 104.62M 104.62M 104.62M 104.62M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis